ArticleThe journal of headache and pain2026
Mesocorticolimbic circuitry in episodic migraine: reward- and punishment-related responses and resting-state connectivity.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Dopaminergic Dysregulation in Migraine: From Hypothalamic A11 Dysfunction to a Systemic Biobehavioral Phenotype.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundClinical evidence suggests an involvement of the dopaminergic system in migraine pathophysiology; however, its functional role remains poorly understood. We investigated neurofunctional alterations within mesocorticolimbic/dopaminergic circuits in individuals with episodic migraine compared with healthy controls.
methodsWe employed a Monetary Incentive Delay (MID) fMRI task to assess mesocorticolimbic function during reward and loss anticipation in individuals with episodic migraine (n = 25) and control subjects (n = 27). Group differences in task-related activity were examined within core mesocorticolimbic regions, including the ventral tegmental area, nucleus accumbens, and medial prefrontal cortex, focusing on the anticipation phase, which has been widely suggested to be sensitive to dopaminergic signaling. Resting-state fMRI was additionally used to assess intrinsic functional connectivity within the same regions.
resultsRepeated-measures ANCOVA indicated reduced mesocorticolimbic activity during anticipation in migraine patients compared with controls. Logistic regression analyses further showed that loss anticipation–related activity discriminated between the two groups. Planned contrasts revealed reduced responses specifically within the nucleus accumbens and ventral tegmental area during loss anticipation. Exploratory analyses showed an association between mesocorticolimbic activity during loss anticipation and the self-reported attack-related pain intensity, although this did not survive correction for multiple comparisons. No significant associations were observed between loss anticipation–related activity with affective symptom severity (BDI, STAI). Supporting these results, resting-state fMRI analyses further revealed altered nucleus accumbens–prefrontal functional connectivity in migraine patients.
interpretationOverall, the observed pattern suggests that individuals with episodic migraine are characterized by a reduction in mesocorticolimbic responsivity, mainly involving the ventral tegmental area and the nucleus accumbens, during reward/loss anticipation processes, but with a preferential reduction in negative-valence (loss) anticipation. These task-related alterations are embedded within an altered nucleus accumbens–prefrontal pathway evident at rest. Together, these findings are consistent with a disturbance of mesocorticolimbic function in episodic migraine, potentially involving dopaminergic mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.